Clinical Trial

To Assess Dose Proportionality and Pharmacokinetic Linearity of Saninova Tablets in Healthy Participants Under Fasting Conditions

Study acronym: Saninova
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
An open-label, randomized, single dose study to assess dose proportionality and pharmacokinetic linearity in healthy participants under fasting condition.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-06-18; most recent amendment 2026-06-29.
Trial Details
NCT Number NCT07664657
Lead Sponsor Sichuan Credit Pharmaceutical Co., Ltd.
Conditions Bioavailability and Pharmacokinetics
Enrollment 32 participants
Start Date 2026-06
Primary Completion 2026-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2026-07-01